Evolution and Adaptation to Caregiver of a Socio-geriatric Evaluation

Aging Clinical Trial

— ESOGER  

Official title:

Socio-geriatric Evaluation (ESOGER): A Clinical Tool in Telehealth to Fight Against Vulnerable Seniors's Health Alterations and Social Isolation

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05062590
• Other study ID #: 2022-616
• Status: Recruiting
• Phase: N/A
• Start date: April 4, 2022
• Est. completion date: March 2026

Study information

• Verified date: February 2024
• Source: Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
• Contact: Olivier Beauchet, MD
• Phone: 514-340-3540
• Email: olivier.beauchet[@]umontreal.ca
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

With the COVID-19 pandemic, elderly people (EP) living at home have seen their health deteriorated, thus increasing their needs in support and care. Indeed, while it was estimated that before the pandemic120 000 unattended living at home EP required care and services (taking bath, access to medication and food, etc.), the number doubled after COVID-19. Therefore, the waiting list for socio-medical services for unattended vulnerable clientele without a family doctor grew from 1300 à 1715 EP in a couple of months during the pandemic. With these numbers, it becomes clear that an intervention is needed. Truly, the Institut National d'Excellence en Santé et Services Sociaux (INESSS) conclude that it was pivotal to first identify the most vulnerable EP and second re-orient them according to their needs. Thus the investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital plateform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. Investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable. For this study, the investigator aims to evaluate the effect of ESOGER on EP physical and mental health, loss of autonomy, social isolation, quality of life and ressources consumption.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 260
• Est. completion date: March 2026
• Est. primary completion date: June 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Aged 65 and more
• Living at home on the territory CIUSSS-Centre-Sud de l'île-de-Montréal (CCSMTL) of Jeanne-Mance
• Brief Geriatric Assessment (BGA) score of 1/14 or more defining a severly to milidly frail health.

Exclusion Criteria:

• Principal address outside of the CCSMTL's Jeanne-Mance territory
• Participate at another clinical trial, to avoid interferences
• Not understand written or spoken French or English, questionnaires are only available in French and English.

Related Conditions & MeSH terms

• Aging
• Social Isolation

Intervention

Other:
• Recommendations
Ressources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP

Locations

Country	Name	City	State
Canada	CRIUGM	Montréal	Quebec

Sponsors (1)

Lead Sponsor	Collaborator
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	COVID-19 symptoms	presence or not of fever, cough, and shortness of breath (binary question)	3 months
Primary	psychological fraility	Anxiety verbal analogic scale, score from 0= no anxiety to 10= extremly anxious	3 months
Primary	Social health	Issues related to medication and food delivery and access to home care. Presence or not of a shortage in food, medication and home care ( binary question)	3 months
Primary	Socio-economic characteristics	Presence or not of socio-economic problems (binary questions)	3 months
Primary	Participant's Quality of life	Measured by the EQ-5D scale with two parts, scale 1 score from 1= no problem to 5 ( sever health problems) and scale 2 visual analogic scale score from 0= worst possible health to 100= best possible health.	3 months
Primary	Autonomy	ADL scale score from 0= very dependent to 6= very independent and IADL scale score 0= not autonomous 4= autonomous.	3 months
Secondary	Caregiver burden	Based on Zarit scale, score from 0= no burden to 16= high caregiver burnder	3 months